Erratum: A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182)

Samuel G. Awuah, Yao Rong Zheng, Peter M. Bruno, Michael T. Hemann, Stephen J. Lippard

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)3250
Number of pages1
JournalJournal of the American Chemical Society
Volume138
Issue number9
DOIs
StatePublished - Mar 9 2016

ASJC Scopus subject areas

  • Catalysis
  • Chemistry (all)
  • Biochemistry
  • Colloid and Surface Chemistry

Fingerprint

Dive into the research topics of 'Erratum: A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182)'. Together they form a unique fingerprint.

Cite this